Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.0%

1 terminated/withdrawn out of 33 trials

Success Rate

92.9%

+6.4% vs industry average

Late-Stage Pipeline

24%

8 trials in Phase 3/4

Results Transparency

8%

1 of 13 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2
6(31.6%)
N/A
5(26.3%)
Phase 3
4(21.1%)
Phase 4
4(21.1%)
19Total
Phase 2(6)
N/A(5)
Phase 3(4)
Phase 4(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (33)

Showing 20 of 33 trials
NCT06430411Not Yet Recruiting

Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study

Role: collaborator

NCT05530395Unknown

BAseLine TEstosterone as a Prognostic and/or Predictive bioMARKer in mHSPC

Role: collaborator

NCT04812938Unknown

Exploiting Pathogenic Tp53 Mutation for Early Diagnosis of Ovarian Cancer by Mean of Papanicolau Test

Role: lead

NCT00916708Not ApplicableUnknown

Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients

Role: lead

NCT03551470Unknown

Minimally Invasive Simultaneous Colorectal and Liver Surgery

Role: lead

NCT02806791Unknown

Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment

Role: lead

NCT02436720Unknown

Upper Limb Assessment in Duchenne Muscular Dystrophy

Role: collaborator

NCT01784549Phase 2Unknown

Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease

Role: collaborator

NCT01652495Phase 4Completed

Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to Corticosteroids Intrabursal Injection

Role: collaborator

NCT01786018Phase 2Unknown

Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas

Role: lead

NCT02023671Unknown

IMMUNOPHENOTYPE ROLE IN THE EVALUATION OF CLINICAL RESPONSE

Role: lead

NCT01524055Phase 3Completed

CO2 Insufflation During Single-Balloon-Enteroscopy

Role: collaborator

NCT01935193Phase 4Unknown

Aspirin Resistance Reversibility in Diabetic Patients

Role: lead

NCT01440556Completed

Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma

Role: lead

NCT01785953Unknown

Conventional and Experimental Chemotherapy With Allogeneic Transplant in Young Patients With Acute Myeloid Leukaemia

Role: lead

NCT01785914Unknown

Retrospective Evaluation of the Clinical Results Obtained in Patients With Acute Lymphoblastic Leukemia Treated at the San Giovanni Battista Hospital.

Role: lead

NCT01287429Completed

Lung Ultrasound for Acute Dyspnea in Emergency Department

Role: collaborator

NCT01523652Completed

Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients

Role: lead

NCT01121341Phase 4Unknown

ESOS (Endoscopic Saphenous Harvesting With an Open CO2 System) Trial

Role: lead

NCT01098916Not ApplicableCompleted

The RAD-HOME Project: a Pilot Study of Domiciliary Teleradiology

Role: lead